Legacy claim assessment · corrected
Primary sources support submission assistance, not demonstrated pricing-accuracy improvements across all commercial product lines.
Assessed Nov 8, 2026. This verdict is separate from deployment evidence and measured outcomes.
Catalog record · Risk Management
Stage as of Not reported · historical report, not live reconfirmation.
AIG Underwriter Assistance: submission preparation and prioritization
Primary workflow source. A named organization's workflow supported by a reviewed primary source. Stage is reported separately; this label does not establish measured outcomes or independent validation.
Last researched Nov 8, 2026. Source access and reported stage are recorded below; deployment evidence does not establish ROI.
What the research supports
AIG uses generative AI to extract and synthesize submission data, augment it with internal and external information, and prioritize submissions for human underwriter review. Its 2025 investor presentation confirms production in selected U.S. Financial Lines and private not-for-profit segments, with expansion in progress.
Original catalog wording · AIG AI Underwriting
AIG uses AI to enhance commercial insurance underwriting, analyzing historical claims data, risk factors, and external data sources to improve pricing accuracy and underwriting efficiency. The system helps underwriters assess complex commercial risks more consistently across product lines.
Archived maturity label: Production. Retained as original wording, not a current deployment assertion.
Original catalog sourceciodive.com · opens in a new tabAudited correction: Source-bound legacy adjudication. Primary sources support submission assistance, not demonstrated pricing-accuracy improvements across all commercial product lines. Original catalog wording is archived; unsupported historical impact ratings, generated summaries and unestablished announcement dates are cleared. Updated fields: title, description, summary, categoryId, maturity, aiTechnology, businessFunction, impact, sourceUrl, sourceType, announcedDate.
- Reported stage
- Production
- Technology
- GenAI/LLM
- Business function
- Front Office
- Impact (legacy label)
- Not labeled
- Catalog date · unconfirmed
- Not reported
- Imported
- Mar 13, 2026
- Last researched
- Nov 8, 2026
Measures & evidence
No quantified measure recorded. This is a gap in the evidence, not a finding of no value.
Documented vendor relationships
No vendor relationship has been linked to this specific workflow in the curated overlay. This does not mean it was built without vendors.
See the company’s documented relationshipsDeployment evidence & limits
Primary sources support submission assistance, not demonstrated pricing-accuracy improvements across all commercial product lines. Status as of 2025.
Stage is as reported in the cited evidence. Current operating status has not been independently reconfirmed; the research date is an editorial review date.
Primary sources support submission assistance, not demonstrated pricing-accuracy improvements across all commercial product lines. 2025 production scope is documented; current extent of rollout was not established. Preparation time is not end-to-end underwriting time or financial savings.
Recorded dependencies
- Human underwriter review of AI output.
Source register
- AIG Leaders Discuss GenAI and the Atlanta Innovation Hubaig.com · opens in a new tab
AIG · issuer · full-text · Published 2025-04-07
- AIG Investor Day 2025 presentation, Exhibit 99.1sec.gov · opens in a new tab
AIG / SEC · filing · full-text · Publication date not recorded
Research lanes: legacy-4 · Batch research-refresh-2026-11-08. Coverage and remaining gaps